<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://insights.citeline.com/medtech-insight/business/earnings/thermo-fisher-raises-guidance-as-q1-results-dodge-tariff-concerns-6F7ZSQWNLRCFLJB6Y5564FVDUA/</loc><lastmod>2026-04-25T14:38:19.86Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T14:38:19.86Z</news:publication_date><news:title><![CDATA[Thermo Fisher Raises Guidance As Q1 Results Dodge Tariff Concerns]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/Hrx3LxYhAcMykSk63lz7fXqqOyw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/24YDLBG3YBJ3JONSKX76OCE6UM.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/ema-clears-path-for-novartis-to-expand-market-for-sma-gene-therapy-itvisma-LMPNF6QTHZFFVCJZ665YDXPLEM/</loc><lastmod>2026-04-25T08:00:19.231Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T08:00:19.231Z</news:publication_date><news:title><![CDATA[EMA Clears Path for Novartis To Expand Market For SMA Gene Therapy Itvisma  ]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/HMBCjbtQ_f3uqGiLc5dDLYhRoZE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5KQNPH3YFZAMJCO6W7NWZZ6OAQ.jpg</image:loc><image:caption><![CDATA[Novartis's intrathecal formulation of its spinal muscular atrophy gene therapy could be approved in the EU soon]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/hbw-insight/beauty/policy-and-regulation/us-fda-finds-banned-chemical-in-six-gel-nail-polish-removers-54PQWO3Q5VD35M64XKXCAVZOZA/</loc><lastmod>2026-04-25T00:50:01.708Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:50:01.708Z</news:publication_date><news:title><![CDATA[US FDA Finds Banned Chemical In Six Gel Nail Polish Removers]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/A5Bu22UGiAw1f6tDQ5HpRQTCO6Q=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GHCX7NZHTNALRBA6UGIPOET37E.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/pathways-and-standards/approval-standards/us-fda-urged-to-modernize-evidence-standards-for-rx-to-otc-switches-MMZ64MZE3BF6RPVALFDUXVD66A/</loc><lastmod>2026-04-25T00:41:26.776Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:41:26.776Z</news:publication_date><news:title><![CDATA[US FDA Urged To Modernize Evidence Standards For Rx-to-OTC Switches ]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/NdmuROJbGEKuWVuGgUNsPYdutCk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3FXHXEKPPBGYFJVK5FKF2UOBIY.jpg</image:loc><image:caption><![CDATA[Stakeholders seek more modern evidence standards for some OTC products.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/pathways-and-standards/approval-standards/precision-psychiatry-targeted-therapy-is-enormous-opportunity-us-fda-official-says-EY3WPEJO5REPBHUKSCWEWRQBFI/</loc><lastmod>2026-04-25T00:22:32.734Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:22:32.734Z</news:publication_date><news:title><![CDATA[Precision Psychiatry: Targeted Therapy Is ‘Enormous Opportunity,’ US FDA Official Says]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/0GTdRHR0knl3Q1e1rM4XcBlesao=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IPTW7PZUQJM5VBG53OG7ELRWGQ.jpg</image:loc><image:caption><![CDATA[Targeted therapy in psychiatry is a huge opportunity but also a long way from realization.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/companies/cormica-ltd/</loc><lastmod>2026-04-25T00:05:36.647Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:05:36.647Z</news:publication_date><news:title><![CDATA[Cormica Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/tortugas-neuroscience-inc/</loc><lastmod>2026-04-25T00:05:26.39Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:05:26.39Z</news:publication_date><news:title><![CDATA[Tortugas Neuroscience, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/chengdu-xinzhenghe-pharmaceutical-technology-co-ltd/</loc><lastmod>2026-04-25T00:05:16.463Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:05:16.463Z</news:publication_date><news:title><![CDATA[Chengdu Xinzhenghe Pharmaceutical Technology Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/serif-biomedicines-inc/</loc><lastmod>2026-04-25T00:05:08.586Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:05:08.586Z</news:publication_date><news:title><![CDATA[Serif Biomedicines Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/cells-first-biotechnology-beijing-co-ltd</loc><lastmod>2026-04-25T00:05:02.799Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:05:02.799Z</news:publication_date><news:title><![CDATA[Cells First Biotechnology (Beijing) Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/beijing-aiger-stem-cell-technology-co-ltd/</loc><lastmod>2026-04-25T00:04:44.51Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:04:44.51Z</news:publication_date><news:title><![CDATA[Beijing Aiger Stem Cell Technology Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/garda-therapeutics</loc><lastmod>2026-04-25T00:04:38.298Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:04:38.298Z</news:publication_date><news:title><![CDATA[Garda Therapeutics]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/cnr-research-co-ltd</loc><lastmod>2026-04-25T00:04:32.236Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:04:32.236Z</news:publication_date><news:title><![CDATA[CNR Research Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/allevion-medical</loc><lastmod>2026-04-25T00:04:26.482Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:04:26.482Z</news:publication_date><news:title><![CDATA[Allevion Medical]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/pridcor-therapeutics-llc/</loc><lastmod>2026-04-25T00:04:20.265Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:04:20.265Z</news:publication_date><news:title><![CDATA[PridCor Therapeutics LLC]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/zonsen-peplib-biotech-inc</loc><lastmod>2026-04-25T00:04:14.317Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:04:14.317Z</news:publication_date><news:title><![CDATA[Zonsen PepLib Biotech Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/aspire-biopharma-holdings-inc</loc><lastmod>2026-04-25T00:04:02.302Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:04:02.302Z</news:publication_date><news:title><![CDATA[Aspire Biopharma Holdings Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/celerion</loc><lastmod>2026-04-25T00:03:56.045Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:56.045Z</news:publication_date><news:title><![CDATA[Celerion]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/shanghai-unixell-biotechnology-co-ltd</loc><lastmod>2026-04-25T00:03:50.071Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:50.071Z</news:publication_date><news:title><![CDATA[Shanghai UniXell Biotechnology Co., Ltd]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/vantis-vascular-inc</loc><lastmod>2026-04-25T00:03:44.053Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:44.053Z</news:publication_date><news:title><![CDATA[Vantis Vascular, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/srx-health-solutions-inc</loc><lastmod>2026-04-25T00:03:37.994Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:37.994Z</news:publication_date><news:title><![CDATA[SRx Health Solutions Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/paraza-pharma-inc</loc><lastmod>2026-04-25T00:03:32.049Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:32.049Z</news:publication_date><news:title><![CDATA[Paraza Pharma, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/cgbio-inc</loc><lastmod>2026-04-25T00:03:26.067Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:26.067Z</news:publication_date><news:title><![CDATA[CGBio, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/vivacta-ltd</loc><lastmod>2026-04-25T00:03:20.129Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:20.129Z</news:publication_date><news:title><![CDATA[Vivacta Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/keymed-biosciences-inc</loc><lastmod>2026-04-25T00:03:13.938Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:13.938Z</news:publication_date><news:title><![CDATA[Keymed Biosciences Inc. ]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/kubota-vision-inc</loc><lastmod>2026-04-25T00:03:08.18Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:08.18Z</news:publication_date><news:title><![CDATA[Kubota Vision Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/jiangsu-wuzhong-industrial-co</loc><lastmod>2026-04-25T00:03:01.851Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:03:01.851Z</news:publication_date><news:title><![CDATA[Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/queens-university-belfast</loc><lastmod>2026-04-25T00:02:55.813Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:55.813Z</news:publication_date><news:title><![CDATA[Queen's University Belfast]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/day-one-biopharmaceuticals-inc/</loc><lastmod>2026-04-25T00:02:49.737Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:49.737Z</news:publication_date><news:title><![CDATA[Day One Biopharmaceuticals, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/ebb-therapeutics</loc><lastmod>2026-04-25T00:02:43.635Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:43.635Z</news:publication_date><news:title><![CDATA[Ebb Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/siemens-healthineers-ag</loc><lastmod>2026-04-25T00:02:37.746Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:37.746Z</news:publication_date><news:title><![CDATA[Siemens Healthineers AG]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/tubulis-gmbh</loc><lastmod>2026-04-25T00:02:31.841Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:31.841Z</news:publication_date><news:title><![CDATA[Tubulis GmbH]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/aicuris-anti-infective-cures-gmbh</loc><lastmod>2026-04-25T00:02:25.816Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:25.816Z</news:publication_date><news:title><![CDATA[AiCuris Anti-infective Cures GmbH]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nanjing-medical-group-ltd</loc><lastmod>2026-04-25T00:02:19.791Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:19.791Z</news:publication_date><news:title><![CDATA[Nanjing Medical University]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/geneoscopy-inc</loc><lastmod>2026-04-25T00:02:07.73Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:07.73Z</news:publication_date><news:title><![CDATA[Geneoscopy, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/achilles-therapeutics-plc</loc><lastmod>2026-04-25T00:02:01.889Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:02:01.889Z</news:publication_date><news:title><![CDATA[Achilles Therapeutics plc]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/viscofan-bioengineering</loc><lastmod>2026-04-25T00:01:55.528Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:01:55.528Z</news:publication_date><news:title><![CDATA[Viscofan BioEngineering]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/vanderbilt-university</loc><lastmod>2026-04-25T00:01:49.439Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:01:49.439Z</news:publication_date><news:title><![CDATA[Vanderbilt University]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/neurocrine-biosciences-inc</loc><lastmod>2026-04-25T00:01:43.501Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:01:43.501Z</news:publication_date><news:title><![CDATA[Neurocrine Biosciences, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/genexine-inc</loc><lastmod>2026-04-25T00:01:34.547Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:01:34.547Z</news:publication_date><news:title><![CDATA[Genexine Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/lytix-biopharma-as</loc><lastmod>2026-04-25T00:01:22.593Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:01:22.593Z</news:publication_date><news:title><![CDATA[Lytix Biopharma AS]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/daiichi-sankyo-co-ltd</loc><lastmod>2026-04-25T00:01:10.625Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:01:10.625Z</news:publication_date><news:title><![CDATA[Daiichi Sankyo Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/gilead-sciences-inc</loc><lastmod>2026-04-25T00:00:58.913Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:00:58.913Z</news:publication_date><news:title><![CDATA[Gilead Sciences, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/assertio-holdings-inc</loc><lastmod>2026-04-25T00:00:46.791Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T00:00:46.791Z</news:publication_date><news:title><![CDATA[Assertio Holdings, Inc.]]></news:title></news:news></url></urlset>